Cover Image

Systematic Review: The Relationship Between the Faecal Microbiome and Colorectal Neoplasia in Shotgun Metagenomic Studies

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Sarah Manning, Eleanor Hackney, Yashvee Dunneram, Mark A. Hull, Suparna Mitra, Christopher J. Stewart, Panayiotis Louca, Nick Meader, Linda Sharp, Colin Rees
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Alimentary Pharmacology & Therapeutics
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Faecal Volatile Organic Compounds to Detect Colorectal Neoplasia in Lynch Syndrome—A Prospective Longitudinal Multicentre Study
by: Elsa L. S. A. van Liere, et al.
Published: (2024)

Faecal incontinence: Retentive, non‐retentive and when to suspect organic pathology
by: Carlo Di Lorenzo
Published: (2024)

Faecal biomarkers for diagnosis and prediction of disease course in treatment‐naïve patients with IBD
by: Maria Ling Lundström, et al.
Published: (2024)

Real‐World Performance of FIT Triage for Symptomatic Colonoscopy: Analysis of the UK National Endoscopy Database ( NED )
by: David Beaton, et al.
Published: (2026)

Letter: Interpreting Faecal SCFA Enrichment in IBS‐D—Metabolic Signal or Transit‐Related Marker?
by: Longying Zhang, et al.
Published: (2026)

Review article: Faecal biomarkers for assessing small intestinal damage in coeliac disease and environmental enteropathy
by: Laura Kivelä, et al.
Published: (2024)

The Association of Faecal Calprotectin Measurements With Endo‐Histological Remission in Ulcerative Colitis: A Pooled Analysis
by: Laurie‐Rose Dubé, et al.
Published: (2026)

Letter: Dose and Donor Matter—Determining the Optimal Strategy for Faecal Microbiota Transplantation in Clostridioides difficile Infection. Authors' Reply
by: Sara Ellegaard Paaske, et al.
Published: (2026)

Research Communication: Reflux Disease May Constitute a Risk Factor for Colonic Neoplasia
by: Amnon Sonnenberg, et al.
Published: (2025)

Limitations of Faecal Calprotectin in Detecting Histological Changes and Persistent Villous Atrophy in Patients With Coeliac Disease on a Gluten‐Free Diet
by: Verónica Segura, et al.
Published: (2025)

Impact of Clinical and Pharmacological Parameters on Faecal Microbiota Transplantation Outcome in Clostridioides difficile Infections: Results of a 5‐Year French National Survey
by: Nicolas Benech, et al.
Published: (2024)

Letter: H. pylori Infection May Constitute a Risk Factor for Reflux Disease and Colonic Neoplasia
by: Jannis Kountouras, et al.
Published: (2025)

Editorial: Surveillance Colonoscopy for Detection of Neoplasia in Inflammatory Bowel Disease—Is Dye‐Based Chromoendoscopy Always the Final Answer?
by: Andrea Cassinotti, et al.
Published: (2025)

Improving Clinical Outcomes of Encapsulated Faecal Microbiota Transplantation for Clostridioides difficile Infection Through Empirical Donor Selection and Optimised Dosing: A Quality Improvement Study
by: Sara Ellegaard Paaske, et al.
Published: (2025)

Editorial: Right‐Sizing Colonoscopy Referrals for Patients With Possible Signs and Symptoms of Colorectal Cancer
by: Nicole P. Mirabadi, et al.
Published: (2025)

Letter: Enhancing Risk‐Adapted Colorectal Cancer Screening for People With Diabetes—Authors' Reply
by: Teresa Seum, et al.
Published: (2025)

Editorial: ‘Risk‐Adapted Starting Ages of Colorectal Cancer Screening for People With Diabetes or Metabolic Syndrome’
by: James Turvill
Published: (2025)

Diagnostic Accuracy of an Add‐On, Blood‐Based Screening Test for Colorectal Cancer in Two Established Screening Programmes
by: Tim L. Kortlever, et al.
Published: (2025)

Letter: Balancing Cost and Consequence of Colon Capsule Endoscopy in Colorectal Cancer Pathways—Finding the Sweet Spot
by: Ian Io Lei, et al.
Published: (2025)

Letter: Methodological Gaps Undermine Conclusions on Electronic Nose Use for Colorectal Cancer Detection—Authors' Reply
by: Milou. L. M. van Riswijk, et al.
Published: (2025)

Editorial: ‘Risk‐Adapted Starting Ages of Colorectal Cancer Screening for People With Diabetes or Metabolic Syndrome’. Authors' Reply
by: Hermann Brenner, et al.
Published: (2025)

Research Communication: Effects of Screening Colonoscopy on Colorectal Cancer Mortality: Lessons From Comparative Analyses of Randomised Trials
by: Hermann Brenner, et al.
Published: (2025)

Editorial: Combination Therapies for MASH : A Step Forward or More Complexity? Authors' Reply
by: Eric Lawitz, et al.
Published: (2025)

Editorial: High‐Grade Dysplasia in Colonic Inflammatory Bowel Disease Is Associated With a High Risk of Synchronous or Metachronous Colorectal Cancer
by: Alexandra Hickey, et al.
Published: (2025)

A Message From the Editors
by: Colin W. Howden, et al.
Published: (2024)

Primary Sclerosing Cholangitis in the Absence of Inflammatory Bowel Disease Increases the Risk of Colorectal Cancer: A Multi‐Centre Propensity Score Matched Analysis
by: Saqr Alsakarneh, et al.
Published: (2025)

Editorial: High‐Grade Dysplasia in Colonic Inflammatory Bowel Disease Is Associated With a High Risk of Synchronous or Metachronous Colorectal Cancer—Authors' Reply
by: Monica E. W. Derks, et al.
Published: (2025)

Editorial: Revisit the causes and long‐term outcomes in cirrhosis patients—Authors' reply
by: Linda Henry, et al.
Published: (2024)

Letter: The Essential Role of Social Workers in Reducing Socioeconomic Disparities in Chronic Liver Disease—Author's Reply
by: Eunice Yewon Lee, et al.
Published: (2024)

Meta‐Analysis: Global Prevalence and Mortality of Cirrhosis in Metabolic Dysfunction‐Associated Steatotic Liver Disease
by: Soroor Owrangi, et al.
Published: (2024)

Integrated Analysis of Vonoprazan Safety for Symptomatic Gastro‐Oesophageal Reflux Disease or Erosive Oesophagitis
by: Colin W. Howden, et al.
Published: (2024)

Review Article: Individualised Management of Reflux‐Like Symptoms—Strategies Beyond Acid Suppression
by: Peter J. Kahrilas, et al.
Published: (2025)

Differential Characteristics and Survival Outcomes of Patients With Cirrhosis According to Underlying Liver Aetiology
by: Yu Shi, et al.
Published: (2025)

Twenty‐Year Trends in Colectomy Rates and Advanced Therapy Prescribing in Lothian, Scotland
by: Alexander T. Elford, et al.
Published: (2025)

No value of non‐selective beta‐blockers after TIPS‐insertion
by: Anja Tiede, et al.
Published: (2024)

Editorial: The future of managing drug induced liver injury
by: Amanda Nicoll
Published: (2024)

Letter: Critical appraisal of biologic therapy in early ulcerative colitis management—Addressing study limitations and the role of psychological resilience—Authors' reply
by: Vibeke Strande, et al.
Published: (2024)

CD300A+CD8+ T Cells as Predictive Biomarkers for Achieving Functional Cure in Chronic Hepatitis B Patients Undergoing Pegylated Interferon‐Alpha Therapy
by: Peng Zhang, et al.
Published: (2025)

Bradycardia and Other Arrhythmias in Patients With Hepatorenal Syndrome‐Acute Kidney Injury Following Terlipressin Treatment: A Pooled Analysis of Three North American Phase III Clinical Studies
by: Jasmohan S. Bajaj, et al.
Published: (2025)

Research Communication: Changing Aetiology of Chronic Liver Diseases in East Asia Pacific and HCC Surveillance in Non‐Cirrhotic Patients
by: Ming Liu, et al.
Published: (2025)